Prevalence of dihydropteroate synthase genotypes before and after the introduction of combined antiretroviral therapy and their influence on the outcome of Pneumocystis pneumonia in HIV-1-infected patients.
about
Prevalence of dihydropteroate synthase genotypes before and after the introduction of combined antiretroviral therapy and their influence on the outcome of Pneumocystis pneumonia in HIV-1-infected patients.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Prevalence of dihydropteroate ...... ia in HIV-1-infected patients.
@en
Prevalence of dihydropteroate ...... ia in HIV-1-infected patients.
@nl
type
label
Prevalence of dihydropteroate ...... ia in HIV-1-infected patients.
@en
Prevalence of dihydropteroate ...... ia in HIV-1-infected patients.
@nl
prefLabel
Prevalence of dihydropteroate ...... ia in HIV-1-infected patients.
@en
Prevalence of dihydropteroate ...... ia in HIV-1-infected patients.
@nl
P2093
P50
P1476
Prevalence of dihydropteroate ...... ia in HIV-1-infected patients.
@en
P2093
Asunción Moreno
Carlos Agustí
Jorge Puig de la Bellacasa
José M Gatell
José M Miró
Manel Solé
Maria Eugenia Valls
Maria Teresa Jiménez de Anta
Míriam J Alvarez-Martínez
P356
10.1016/J.DIAGMICROBIO.2010.04.007
P577
2010-09-01T00:00:00Z